RJA
EMN icon

Ross\Johnson & Associates’s Eastman Chemical EMN Stock Holding History

Ross\Johnson & Associates’s Portfolio EMN Stock Details EMN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$201 Buy
3
+1
+50% +$73 ﹤0.01% 228
2026
Q1 		$153 Hold
2
– – ﹤0.01% 189
2025
Q4 		$128 Hold
2
– – ﹤0.01% 282
2025
Q3 		$126 Hold
2
– – ﹤0.01% 196
2025
Q2 		$149 Hold
2
– – ﹤0.01% 186
2025
Q1 		$176 Buy
+2
New +$189 ﹤0.01% 320

Other funds holding EMN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

Ross\Johnson & Associates's EMN Position: Q2 2026 in Review

Ross\Johnson & Associates increased its Eastman Chemical (EMN) stake by 50% in Q2 2026, buying an estimated $73 and bringing the position to 3 shares worth $201. The position accounts for ﹤0.01% of the portfolio, ranked #228.

Ross\Johnson & Associates first reported a position in EMN in Q1 2025 and has held it in 6 quarters since. 642 funds tracked by Wall St. Rank hold EMN as of Q2 2026.

  • Ross\Johnson & Associates held 3 shares of Eastman Chemical worth $201 as of Q2 2026.
  • Ross\Johnson & Associates bought 1 Eastman Chemical share in Q2 2026, an estimated $73.
  • Eastman Chemical made up ﹤0.01% of Ross\Johnson & Associates's portfolio in Q2 2026, its #228 holding.
  • Ross\Johnson & Associates first reported a position in Eastman Chemical in Q1 2025 and has held it in 6 quarters since.
  • 642 funds tracked by Wall St. Rank held Eastman Chemical as of Q2 2026.

Based on Ross\Johnson & Associates's 13F filing for Q2 2026, filed 14 Aug 2026.